Serum sensitivity of a Pseudomonas aeruginosa mucoid strain

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Infection and Immunity

• Publication date

  1984-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/iai.45.3.748-755.1984PMID 6432698PMCID PMC263361
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.

  2009cited by this paper
• Development of an enzyme-linked immunosorbent assay for studying Pseudomonas aeruginosa cell surface antigens

  1984cited by this paper
• Infections caused by Pseudomonas aeruginosa.

  1983cited by this paper
• Killing of an Encapsulated Strain of Escherichia coli by Human Serum

  1983cited by this paper
• A complement-sensitive mutant of Pseudomonas aeruginosa.

  1983cited by this paper
• Plasmid-mediated and temperature-regulated surface properties of Yersinia enterocolitica

  1983cited by this paper
• Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains

  1983cited by this paper
• Bactericidal and bacteriolytic activity of serum against gram-negative bacteria

  1983influential reference
• Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

  1983cited by this paper
• Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains

  1983cited by this paper
• The serum sensitivity, colonial morphology, serogroup specificity, and outer membrane protein of Pseudomonas aeruginosa strains isolated from several clinical sites.

  1983cited by this paper
• Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels

  1983cited by this paper
• Serum-induced lysis ofPseudomonas aeruginosa

  1982cited by this paper
• A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

  1982cited by this paper
• Serum bactericidal effect on Pseudomonas aeruginosa isolates from cystic fibrosis patients

  1981cited by this paper
• How complement kills E. coli. II. The apparent two-hit nature of the lethal event.

  1981cited by this paper
• How complement kills E. coli. I. Location of the lethal lesion.

  1981cited by this paper
• Susceptibility of Pseudomonas aeruginosa to serum bactericidal activity. A comparison of three methods with clinical correlations.

  1981cited by this paper
• Lipopolysaccharide heterogeneity in Salmonella typhimurium analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis.

  1980cited by this paper
• Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis

  1980cited by this paper
• Heterogeneity of antigenic-side-chain length in lipopolysaccharide from Escherichia coli 0111 and Salmonella typhimurium LT2.

  1980cited by this paper
• Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins

  1979cited by this paper
• Synergy between carbenicillin and an aminoglycoside (gentamicin or tobramycin) against Pseudomonas aeruginosa isolated from patients with endocarditis and sensitivity of isolates to normal human serum.

  1979cited by this paper
• The effect of the growth environment on the serum sensitivity of some urinary Escherichia coli strains

  1978cited by this paper
• The heterocytotoxicity of human serum. I. Activation of the alternative complement pathway by heterologous target cells.

  1977cited by this paper
• Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.

  1977cited by this paper
• Comparison of ethyleneglycoltetraacetic acid and its magnesium salt as reagents for studying alternative complement pathway function

  1977cited by this paper
• Ultrastructural surface alterations of serratia marcescens after exposure to polymyxin B and/or fresh human serum.

  1976cited by this paper
• Studies on the additive effect of polymyxin B and the bactericidal activity of human serum against Serratia marcescens.

  1975cited by this paper
• The relationship between the O-antigenic lipopolysaccharides and serological specificity in strains of Pseudomonas aeruginosa of different O-serotypes.

  1973cited by this paper
• Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors.

  1972cited by this paper
• Human immunity to Pseudomonas aeruginosa. II. Relationship between heat-stable opsonins and type-specific lipopolysaccharides.

  1972cited by this paper
• Biological Activities of Rabbit Immunoglobulin M and Immunoglobulin G Antibodies to Pseudomonas aeruginosa

  1970cited by this paper
• Sensitivity of serologically classified strains of escherichia coli of human origin to the serum bactericidal system.

  1970cited by this paper
• Sensitivity of Pseudomonas aeruginosa to Normal Serum and to Polymyxin

  1969cited by this paper
• [Studies on the immune bacteriolysis. XIV. Requirement of all nine components of complement for immune bacteriolysis].

  1968cited by this paper
• A kinetic study of the bacteriolytic and bactericidal action of human serum.

  1967cited by this paper
• KINETICS OF THE BACTERICIDAL ACTION OF NORMAL SERUM ON GRAM-NEGATIVE BACTERIA.

  1965cited by this paper
• ASSOCIATION OF "NATURAL" ANTIBODIES TO GRAM-NEGATIVE BACTERIA WITH THE γ1-MACROGLOBULINS

  1963cited by this paper
• THE COMPLEMENT-DEPENDENT BACTERIOLYTIC ACTIVITY OF NORMAL HUMAN SERUM

  1962cited by this paper
• A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION.

  1960cited by this paper
• PREVALENCE OF ANTIBODY TO PSEUDOMONAS IN NORMAL HUMAN SERA

  1955cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• Lysozyme

  1932cited by this paper

• Development of Serum Bactericidal Assay for P. aeruginosa

  2017cites this paper
• [Lysozyme--occurrence in nature, biological properties and possible applications].

  2014cites this paper
• Pseudomonas aeruginosa Alkaline Protease Blocks Complement Activation via the Classical and Lectin Pathways

  2012cites this paper
• Classical and Lectin Pathways Blocks Complement Activation via the Alkaline Protease Pseudomonas aeruginosa

  2011cites this paper
• Bacteriophages as a potential treatment for Pseudomonas aeruginosa mediated chest infections in cystic fibrosis patients

  2011cites this paper
• Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis

  2011cites this paper
• [The efficiency of the bactericidal action of serum raised by complement and lysozyme against bacteria which avoid the immunological response of higher organisms].

  2009cites this paper
• Killing of Gram-Negative Bacteria with Normal Human Serum and Normal Bovine Serum: Use of Lysozyme and Complement Proteins in the Death of Salmonella Strains O48

  2009cites this paper
• Differences among Shigellu spp . in Susceptibility to the Bactericidal Activity of Human Serum

  2008cites this paper
• Cooperation between lysozyme and complement system in bactericidal action of human serum - is everything already clear?

  2008cites this paper
• Isolation of Infectious Cystic Fibrosis Patients: Results of a Systematic Review

  2005cites this paper
• Cystic fibrosis lung disease: genetic influences, microbial interactions, and radiological assessment

  2005cites this paper
• Lung Infections Associated with Cystic Fibrosis

  2002cites this paper
• The evolution of human pathogens: examples and clinical implications.

  2000cites this paper
• Mesophilic Aeromonas sp. serogroup O:11 resistance to complement-mediated killing

  1996cites this paper
• Aeromonas salmonicida resistance to complement-mediated killing

  1994cites this paper
• Profiles of outer membrane proteins and lipopolysaccharide of Pseudomonas aeruginosa grown in the presence of sub-MICs of macrolide antibiotics and their relation to enhanced serum sensitivity.

  1994cites this paper
• Studies on the influence of ozone on complement-mediated killing of bacteria.

  1994cites this paper
• Complement activation by Pseudomonas aeruginosa biofilms.

  1993cites this paper
• Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing

  1992cites this paper
• Effects ofAlginase ontheNatural History andAntibiotic Therapy ofExperimental Endocarditis CausedbyMucoid Pseudomonas aeruginosa

  1992cites this paper
• Establishment of Stable Cell Lines Producing Anti‐Pseudomonas aeruginosa Monoclonal Antibodies and Their Protective Effects for the Infection in Mice

  1992cites this paper
• Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosa

  1992cites this paper
• Cystic fibrosis. Infection and immunity to Pseudomonas.

  1991cites this paper
• Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa

  1991cites this paper
• Infection and immunity toPseudomonas

  1991cites this paper
• [Effect of macrolide antibiotics on human serum-bactericidal sensitivity of Pseudomonas aeruginosa S-6].

  1991cites this paper
• The role of lipopolysaccharide in complement-killing of Aeromonas hydrophila strains of serotype O:34.

  1991cites this paper
• Microbiology of airway disease in patients with cystic fibrosis

  1991cites this paper
• Infection and Immunity to Pseudomonas

  1990cites this paper
• Complement activation and C3 binding by serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa

  1989cites this paper
• Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway

  1988cites this paper
• Characterization of the susceptibility of Pseudomonas aeruginosa to complement-mediated killing: role of antibodies to the rough lipopolysaccharide on serum-sensitive strains

  1988cites this paper
• Interaction of Pseudomonas Aeruginosa with Complement

  1988cites this paper
• The role of complement in host defense against Pseudomonas aeruginosa

  1988cites this paper
• Differences among Shigella spp. in susceptibility to the bactericidal activity of human serum.

  1988cites this paper
• Role of lipopolysaccharide and complement in susceptibility of Escherichia coli and Salmonella typhimurium to non-immune serum.

  1988cites this paper
• Haemophilus influenzae type b lipooligosaccharide: stability of expression and association with virulence

  1987cites this paper
• Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum

  1987cites this paper
• The interaction of complement components with Aeromonas species.

  1986cites this paper
• Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa

  1986cites this paper
• Increased susceptibility of gentamincin-resistantPseudomonas aeruginosa to human sera

  1986cites this paper
• Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum

  1985cites this paper